Intrinsic Value

Viridian Therapeutics, Inc. (VRDN)

$12.7

-0.33 (-2.53%)

Enterprise Value -561.32
Net Debt -81.78
Equity Value -479.55
Shares Outstanding 44.76
Equity Value Per Share -10.71



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt